Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more
Impact factor 2021

CiteScore measures average citations received per document published.

See more
Citescore 2022

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2022

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2022
View more metrics
Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Cavin1 activates the Wnt/β-catenin pathway to influence the proliferation and migration of hepatocellular carcinoma
Xingyuan Hao, Jinghua Li, Bin Liu, Wei Jing, Yonghua Guo, Fusheng Liu, Xiaomian Li, Xi Chen, Yufeng Yuan, Weijie Ma
Full text access
Uncorrected Proof. Available online 1 October 2023
Brushing your teeth may be good for your liver: Linking oral health to non-alcoholic fatty liver disease
Yusuf Yilmaz
Full text access
Uncorrected Proof. Available online 29 September 2023
Global prevalence of occult HBV infection in children and adolescents: A systematic review and meta-analysis
Jiaying Wu, Jiayao He, Hongmei Xu
Full text access
Uncorrected Proof. Available online 29 September 2023
View all Ahead of print
Current Issue
Vol. 28. Issue 5.
(September - October 2023)
Editorial board
Ann Hepatol. 2023;28:101146
Full text access
Gut dysbiosis in alcoholic liver disease: Wonderful dilemma?
Ludovico Abenavoli, Emidio Scarpellini
Ann Hepatol. 2023;28:101123
Full text access
Nonalcoholic fatty liver disease: A risk factor for chronic kidney disease
Kellyane Dias Carvalho, Carla Daltro, Raquel Rocha, Helma P. Cotrim
Ann Hepatol. 2023;28:101122
Full text access
Concise reviews
Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms
Xiaoyi Wang, Zhen Yang, Ying Ran, Long Li, Bangmao Wang, Lu Zhou
Ann Hepatol. 2023;28:101121
Full text access
View all issue
Issues in progress
View all issues in progress
View all archive
View all supplements
Instructions for authors
Special content about COVID-19
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases
Mahak Chauhan, Ihechiluru Nzeako, Feng Li, Paul J. Thuluvath
Open access
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease
Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano
Open access
View all COVID-19 artciles
Most often read
Original article
Alexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:
This article has been read 10.464 times
View all Most Often read articles
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos